GlassScriptPhysician profile
Leakna Ung
NPI 1821525338
$928.39
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $150 · 2021: $133 · 2022: $61.62 · 2023: $192 · 2024: $65.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $541.58 | 2019-2023 | Prostep |
| Wright Medical Technology, INC. | $70.87 | 2019-2020 | |
| Kerecis Limited | $58.96 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $44.37 | 2022-2023 | Dalvance, Avycaz |
| Kowa Pharmaceuticals America, INC. | $39.45 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $34.34 | 2023 | Motoband |
| Grt US Holding, INC. | $23.48 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.84 | 2023 | Nuzyra |
| Treace Medical Concepts, INC. | $20.00 | 2022 | |
| Medtronic, INC. | $17.54 | 2023 | Intellis Adaptivestim |
| Ani Pharmaceuticals, INC. | $15.59 | 2024 | Purified Cortrophin Gel |
| Paragon 28, INC. | $15.50 | 2023 | Silverback |
| Boston Scientific Corporation | $13.49 | 2024 | Wavewriter Alpha Prime 16 |
| Misonix INC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leakna Ung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.